American Thoracic Society
Misuse of common antibiotic is creating resistant TB
Published in TB and Outbreaks Week, August 25th, 2009
Use of a common antibiotic may be undercutting its utility as a first-line defense against drug-resistant tuberculosis (TB). Fluoroquinolones are the most commonly prescribed class of antibiotics in the U.S. and are used to fight a number of different infections such as sinusitis and pneumonia. They are also an effective first line of defense against TB infections that show drug resistance. New research shows, however, that widespread general use of fluoroquinolones may be creating a strain of fluoroquinolone-resistant TB.
The results are published in the August 15 issue of the American Thoracic Society's American Journal of Respiratory and Critical Care...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- Research
Got influenza? Blood genomic signature provides clues to etiology of respiratory infections - University of New South Wales
New drug-resistant TB strains could become widespread says new study - Flu Vaccines
NanoPass Makes its MicronJet Technology Available to Increase Global Supply of Pandemic Influenza Vaccines - Obesity
Certain Behavioral Traits and Feeding Practices May Increase Risk for Weight Gain in Children - Adenovirus
Reports summarize adenovirus research from Umea University - Allergies
Studies from National Institute of Allergy and Infectious Diseases add new findings in the area of allergies - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
